• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza

tetano

Editor, Senior Moderator
J Clin Microbiol. 2010 Jul 28. [Epub ahead of print]
Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza.

Operario DJ, Moser MJ, St George K.

Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, New York; EraGen BioSciences, Madison, Wisconsin.
Abstract

A C-to-T transition mutation in the neuraminidase gene from seasonal A/H1N1 causes a His to Tyr mutation at amino acid position 275 (H274Y, universal N2 numbering), conferring resistance against oseltamivir (Tamiflu). This mutation was first detected in clinical samples in Europe during the 2007-2008 influenza season. Viruses with this mutation reached a prevalence of approximately 11% by the end of the season in North American isolates tested by the CDC. We developed a highly sensitive and specific quantitative real-time reverse transcriptase PCR assay to detect the H274Y mutation. This assay utilizes a 5'-methyl-isocytosine (isoC) residue and fluorescent reporters on genotype-specific primers. During PCR, a quencher coupled to isoguanine (isoG) is site-specifically incorporated complementary to the isoC/dye, resulting in loss of fluorescence. Optimization of primers and assay conditions produced a limit of detection of 100 gene copies per reaction for both wild-type and H274Y genotypes. In samples with mixed populations, it can reliably detect as little as a 1% wild-type or a 0.1% H274Y component. This high sensitivity makes the assay usable on samples with viral loads too low for dideoxy- or pyrosequencing analysis. Additionally, the assay distinguishes seasonal A/H1N1 from A/H3N2, influenza B, or 2009 pandemic A/H1N1, making it useful for influenza subtyping as well as for drug resistance detection. We probed seasonal A/H1N1 samples from the 2005-06, 2006-07, and 2007-08 influenza seasons. Data from the new assay closely matched available drug-resistance genotype data previously determined by dideoxy sequencing. The H274Y mutation was only found in samples from the 2007-08 season.

PMID: 20668122 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20668122
 
Back
Top Bottom